Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
Withdrawn applications
Get the latest updates from Withdrawn applications directly as they happen.
Follow now 204 followers
Latest posts
Last updated 4 days ago
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application withdrawn
4 days ago
Human medicines European public assessment report (EPAR): Azacitidine Adienne, azacitidine, Status: Application...
Withdrawn application: BiResp Spiromax, 27/04/2026
about 1 month ago
Withdrawn application: BiResp Spiromax, 27/04/2026
Withdrawn application: DuoResp Spiromax, 27/04/2026
about 1 month ago
Withdrawn application: DuoResp Spiromax, 27/04/2026
Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn
2 months ago
Human medicines European public assessment report (EPAR): Orblid, bevacizumab, Status: Application withdrawn
Withdrawn application: Pluvicto, 23/04/2026
3 months ago
Withdrawn application: Pluvicto, 23/04/2026
Human medicines European public assessment report (EPAR): Viokat, diazoxide choline, Status: Application withdrawn
3 months ago
Human medicines European public assessment report (EPAR): Viokat, diazoxide choline, Status: Application...
Veterinary medicines European public assessment report (EPAR): Equidormin, midazolam, Status: Application withdrawn
4 months ago
Veterinary medicines European public assessment report (EPAR): Equidormin, midazolam, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Application withdrawn
4 months ago
Human medicines European public assessment report (EPAR): Blarcamesine Anavex, blarcamesine, Status: Application...
Veterinary medicines European public assessment report (EPAR): Cunitraxx, fenbendazole, Status: Application withdrawn
4 months ago
Veterinary medicines European public assessment report (EPAR): Cunitraxx, fenbendazole, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Zumrad, sasanlimab, Status: Application withdrawn
5 months ago
Human medicines European public assessment report (EPAR): Zumrad, sasanlimab, Status: Application withdrawn
Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn
7 months ago
Human medicines European public assessment report (EPAR): Omforro, midazolam, Status: Application withdrawn